CCND1 and pancreatic neoplasm: NF-κB activation is involved in the inhibition of apoptosis, induction of mitogenic gene products such as cyclin D1, increased expression of proangiogenic factors, and regulation of gene products that promote migration and invasion of pancreatic cancer cells, which together contribute to the chemoresistance of pancreatic cancer [45–49].